Lungscape: Resected Non–Small-Cell Lung Cancer Outcome by Clinical and Pathological Parameters-Reference-Cited by-同舟云学术

Lungscape: Resected Non–Small-Cell Lung Cancer Outcome by Clinical and Pathological Parameters

Published:2014-11 Issue:11 Volume:9 Page:1675-1684
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Peters Solange,Weder Walter,Dafni Urania,Kerr Keith M.,Bubendorf Lukas,Meldgaard Peter,O’Byrne Kenneth J.,Wrona Anna,Vansteenkiste Johan,Felip Enriqueta,Marchetti Antonio,Savic Spasenija,Lu Shun,Smit Egbert,Dingemans Anne-Marie,Blackhall Fiona H.,Baas Paul,Camps Carlos,Rosell Rafael,Stahel Rolf A.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference26 articles.

1. Group NM-aC. Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data;Arriagada;Lancet,2010

2. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours;Goldstraw;J Thorac Oncol,2007

3. New driver mutations in non-small-cell lung cancer;Pao;Lancet Oncol,2011

4. Squamous cell carcinoma of the lung: molecular subtypes and therapeutic opportunities;Perez-Moreno;Clin Cancer Res,2012

5. A class of K-sample tests for comparing the cumulative incidence of a competing risk;Gray;Ann Stat,1988

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ROS1 fusions in resected stage I-III adenocarcinoma: Results from the European Thoracic Oncology Platform Lungscape project;Lung Cancer;2024-08

2. Implementing circulating tumor DNA as a prognostic biomarker in resectable non-small cell lung cancer;Trends in Cancer;2024-07

3. EGFR mutation testing, treatment and survival in stage I–III non-small cell lung cancer: CancerLinQ Discovery database retrospective analysis;Future Oncology;2024-06-25

4. miR-185-5p May Modulate the Chemosensitivity of LUSC to Cisplatin via Targeting PCDHA11: Multi-omics Analysis and Experimental Validation;Biochemical Genetics;2024-04-13

5. Ros1 Fusions in Resected Stage I-Iii Adenocarcinoma: Results from the European Thoracic Oncology Platform Lungscape Project;2024